dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Sabaté Gallego, Mònica |
dc.contributor.author | Vidal Guitart, Xavier |
dc.contributor.author | Ballarin Alins, Maria Elena |
dc.contributor.author | Rottenkolber, M. |
dc.contributor.author | Schmied, S. |
dc.contributor.author | Grave, B. |
dc.contributor.author | Ibáñez, Luisa |
dc.date.accessioned | 2022-05-31T09:06:46Z |
dc.date.available | 2022-05-31T09:06:46Z |
dc.date.issued | 2021-11 |
dc.identifier.citation | Sabaté M, Vidal X, Ballarin E, Rottenkolber M, Schmiedl S, Grave B, et al. Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008-2015). Front Pharmacol. 2021 Nov;12:682890. |
dc.identifier.issn | 1663-9812 |
dc.identifier.uri | https://hdl.handle.net/11351/7604 |
dc.description | Anticoagulants; Europa; Fibril·lació auricular no valvular |
dc.description.sponsorship | The project has received support from the European Medicines Agency under the Framework service contract (nr EMA/2015/27/PH) with regard to the reopening of competition no. 3. K. Janhsen (Witten/Herdecke University, Alfred-Herrhausen-Straße 50, 58448 Witten, Germany (UW/GH)) and A. Heeke (AOK NORDWEST, Kopenhagener Straße 1, 44269 Dortmund, Germany). R. Gerlach and M. Tauscher (National Association of Statutory Health Insurance Physicians of Bavaria, Elsenheimerstr. 39, MD-80687 Munich, Germany). The authors from the BIFAP database would like to acknowledge the excellent collaboration of the primary care general practitioners and pediatricians, and also the support of the regional governments to the database. This study is based in part on data from the ‘base de datos para la investigación Farmacoepidemiológica en Atención Primaria’ (BIFAP) fully financed by the Spanish Agency on Medicines and Medical Devices (AEMPS). The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the EMA (European Medicines Agency) or one of its committees or working parties, or AEMPS (Agencia Española de Medicamentos y Productos Sanitarios). The authors thank Alethea Charlton for her support reviewing and editing the English. The authors thank SIDIAP (Sistema d’informació per al Desenvolupament de Investigació en Atenció Primària) for providing the data with respect to CPRD, approval of the study protocol was granted by the Independent Scientific Advisory Committee of the Medicines and Healthcare Products Regulatory Agency (protocol 17_089R). |
dc.language.iso | eng |
dc.publisher | Frontiers Media |
dc.relation.ispartofseries | Frontiers in Pharmacology;12 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Medicació oral |
dc.subject | Fibril·lació auricular - Tractament |
dc.subject | Medicaments - Ús |
dc.subject.mesh | Atrial Fibrillation |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Drug Utilization |
dc.subject.mesh | Administration, Oral |
dc.title | Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008–2015) |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3389/fphar.2021.682890 |
dc.subject.decs | fibrilación atrial |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | utilización de medicamentos |
dc.subject.decs | administración oral |
dc.relation.publishversion | https://doi.org/10.3389/fphar.2021.682890 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sabaté M, Vidal X, Ibáñez L] Fundació Institut Català de Farmacologia (FICF), Barcelona, Spain. Servei de Farmacologia Clínica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, Toxicologia i Terapèutica, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Ballarin E] Fundació Institut Català de Farmacologia (FICF), Barcelona, Spain. Servei de Farmacologia Clínica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Rottenkolber M] Diabetes Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany. [Schmiedl S] Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany. Philipp Klee-Institute for Clinical Pharmacology, Helios University Hospital Wuppertal, Wuppertal, Germany. [Grave B] AOK NORDWEST, Dortmund, Germany |
dc.identifier.pmid | 34803665 |
dc.identifier.wos | 000720117800001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |